Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Cell Biochem ; 96(4): 858-68, 2005 Nov 01.
Article in English | MEDLINE | ID: mdl-16149067

ABSTRACT

Endothelin-1 (ET-1) is implicated in the fibrotic responses characterizing interstitial lung diseases, as well as in the airway remodeling process occurring in asthma. Within such a context, the aim of our study was to investigate, in primary cultures of normal human lung fibroblasts (NHLFs), the ET-1 receptor subtypes, and the intracellular signal transduction pathways involved in the proliferative effects of this peptide. Therefore, cells were exposed to ET-1 in the presence or absence of an overnight pre-treatment with either ET(A) or ET(B) selective receptor antagonists. After cell lysis, immunoblotting was performed using monoclonal antibodies against the phosphorylated, active forms of mitogen-activated protein kinases (MAPK). ET-1 induced a significant increase in MAPK phosphorylation pattern, and also stimulated fibroblast proliferation and IL-6/IL-11 release into cell culture supernatants. All these effects were inhibited by the selective ET(A) antagonist BQ-123, but not by the specific ET(B) antagonist BQ-788. The stimulatory influence of ET-1 on IL-11, but not on IL-6 secretion, was prevented by MAPK inhibitors. Therefore, such results suggest that in human lung fibroblasts ET-1 exerts a profibrogenic action via an ET(A) receptor-dependent, MAPK-mediated induction of IL-11 release and cell proliferation.


Subject(s)
Endothelin-1/pharmacology , Fibroblasts/cytology , Fibroblasts/metabolism , Interleukin-11/metabolism , Lung/cytology , Mitogen-Activated Protein Kinases/metabolism , Receptor, Endothelin A/metabolism , Cell Proliferation/drug effects , Cell Survival/drug effects , Endothelin A Receptor Antagonists , Endothelin B Receptor Antagonists , Endothelin-1/metabolism , Fibroblasts/drug effects , Humans , Interleukin-6/metabolism , Phosphorylation/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptor, Endothelin A/genetics , Receptor, Endothelin B/genetics , Time Factors
2.
J Cell Biochem ; 93(1): 142-52, 2004 Sep 01.
Article in English | MEDLINE | ID: mdl-15352171

ABSTRACT

The airway epithelium is continuously exposed to inhaled oxidants, including airborne pollutants and cigarette smoke, which can exert harmful proinflammatory and cytotoxic effects. Therefore, the aim of our study was to investigate, in primary cultures of human bronchial epithelial cells (HBEC), the signal transduction pathways activated by increasing concentrations (0.25, 0.5, and 1 mM) of hydrogen peroxide (H(2)O(2)), as well as their effects on IL-8 production and cell viability. The reported results show that H(2)O(2) elicited, in a concentration-dependent fashion, a remarkable increase in phosphorylation-dependent activation of mitogen-activated protein kinases (MAPKs), associated with a significant induction of IL-8 synthesis and a dramatically enhanced cell death. Pre-treatment of HBEC with MAPK inhibitors was able to significantly inhibit the effects of H(2)O(2) on IL-8 secretion, and to effectively prevent cell death. Therefore, these findings suggest that MAPKs play a key role as molecular transducers of the airway epithelial injury triggered by oxidative stress, as well as potential pharmacologic targets for indirect antioxidant intervention.


Subject(s)
Bronchi/drug effects , Hydrogen Peroxide/pharmacology , Interleukin-8/biosynthesis , Mitogen-Activated Protein Kinases/metabolism , Oxidants/pharmacology , Respiratory Mucosa/drug effects , Bronchi/metabolism , Caspases/metabolism , Cell Survival/drug effects , Cells, Cultured , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Humans , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Oxidative Stress/physiology , Phosphorylation/drug effects , Respiratory Mucosa/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...